BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32817412)

  • 1. Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease.
    Vacchi E; Burrello J; Di Silvestre D; Burrello A; Bolis S; Mauri P; Vassalli G; Cereda CW; Farina C; Barile L; Kaelin-Lang A; Melli G
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32817412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.
    Vacchi E; Burrello J; Burrello A; Bolis S; Monticone S; Barile L; Kaelin-Lang A; Melli G
    Biomedicines; 2021 Feb; 9(3):. PubMed ID: 33669043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
    Goldstein DS; Kopin IJ; Sharabi Y; Holmes C
    Clin Auton Res; 2015 Feb; 25(1):61-7. PubMed ID: 25638582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
    Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
    Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicle Surface Markers as a Diagnostic Tool in Transient Ischemic Attacks.
    Burrello J; Bianco G; Burrello A; Manno C; Maulucci F; Pileggi M; Nannoni S; Michel P; Bolis S; Melli G; Vassalli G; Albers GW; Cianfoni A; Barile L; Cereda CW
    Stroke; 2021 Oct; 52(10):3335-3347. PubMed ID: 34344167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
    Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red flags for multiple system atrophy.
    Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
    Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
    Marques TM; van Rumund A; Oeckl P; Kuiperij HB; Esselink RAJ; Bloem BR; Otto M; Verbeek MM
    Neurology; 2019 Mar; 92(13):e1479-e1486. PubMed ID: 30814322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
    Jiang C; Hopfner F; Katsikoudi A; Hein R; Catli C; Evetts S; Huang Y; Wang H; Ryder JW; Kuhlenbaeumer G; Deuschl G; Padovani A; Berg D; Borroni B; Hu MT; Davis JJ; Tofaris GK
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):720-729. PubMed ID: 32273329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant.
    Castellani C; Burrello J; Fedrigo M; Burrello A; Bolis S; Di Silvestre D; Tona F; Bottio T; Biemmi V; Toscano G; Gerosa G; Thiene G; Basso C; Longnus SL; Vassalli G; Angelini A; Barile L
    J Heart Lung Transplant; 2020 Oct; 39(10):1136-1148. PubMed ID: 32665078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
    Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Front Immunol; 2019; 10():2253. PubMed ID: 31616427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K; Zeng Y; Song C; Fu Y; Wan Q
    J Neurol; 2010 Sep; 257(9):1486-91. PubMed ID: 20405138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Krismer F; Seppi K; Göbel G; Steiger R; Zucal I; Boesch S; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Mov Disord; 2019 Jul; 34(7):1041-1048. PubMed ID: 30919495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles.
    Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J
    Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study.
    Kiryu S; Yasaka K; Akai H; Nakata Y; Sugomori Y; Hara S; Seo M; Abe O; Ohtomo K
    Eur Radiol; 2019 Dec; 29(12):6891-6899. PubMed ID: 31264017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy.
    Pilleri M; Levedianos G; Weis L; Gasparoli E; Facchini S; Biundo R; Formento-Dojot P; Antonini A
    Parkinsonism Relat Disord; 2014 Feb; 20(2):217-21. PubMed ID: 24290883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.
    Péran P; Barbagallo G; Nemmi F; Sierra M; Galitzky M; Traon AP; Payoux P; Meissner WG; Rascol O
    Mov Disord; 2018 Apr; 33(4):600-608. PubMed ID: 29473662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.